This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. Research Beam Model: Research Beam Product ID: 16093 3950 USD New
2014 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2014 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

 
  • Category : Diagnostic and Biotech
  • Published On : April  2014
  • Pages : 0
 
 

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.



This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. 



The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.



Blood Group Genotyping



PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR,

Real Time PCR, Sanger DNA Sequencing, Pyrosequencing



Microarrays



BeadChip Array, BloodChip, Genome Lab SNP Stream,

Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS,

Mini-Sequencing



Blood Typing and Grouping Tests



ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, 

Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), 

Antiglobulin (Direct, C3 + IgG, IgG,  C3), 

Crossmatching (Immediate Spin, Full Crossmatch), 

Rh (D, Du).



Infectious Disease Screening Tests



AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, 

Hepatitis (HAV NAT, HBV NAT, HBs Ag,   

Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, 

Syphilis, West Nile Virus NAT



Sales and Market Share Analysis



Sales and market share estimates for leading

suppliers of blood banking products by individual product.



Competitive Assessments



Strategic assessments of major suppliers and 

emerging market entrants, including their sales,

product portfolios, marketing tactics, and new products in R&D.



Market Segmentation Analysis



- Comprehensive market segmentation

  analysis, including review of the market

  dynamics, trends, structure, size, growth,

  and key suppliers.



- Test volume and sales forecasts for over 40 blood typing, 

  grouping and infectious disease screening tests,

  including NAT, by market segment:



     - Blood Centers

     - Hospitals

     - Commercial/Private Laboratories



Current and Emerging Products



- Analysis of current and emerging blood typing, 

  grouping and infectious disease screening tests.



- Review of automated and semi-automated

  analyzers.



Technology Review



- Assessment of current and emerging

  technologies, and their potential applications

  for the blood banking market.



- Comprehensive lists of companies developing

  or marketing new technologies and products, by test.



Strategic Recommendations



- New product development

  opportunities with significant market appeal.



- Alternative market penetration strategies.



- Potential market entry barriers and risks.

                                                                              

Contains 430 pages and 35 tables